We are live on ! Find out more
LAB icon

Standard BioTools
LAB

80 hedge funds and large institutions have $154M invested in Standard BioTools in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 19

23% more call options, than puts

Call options by funds: $342K | Put options by funds: $278K

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

0.52% more ownership

Funds ownership: 92.38% → 92.9% (+0.52%)

4% less funds holding

Funds holding: 83 → 80 (-3)

21% less capital invested

Capital invested by funds: $196M → $154M (-$41.3M)

Holders
80
Holders Change
-3
Holders Change %
-3.61%
% of All Funds
1.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
29
Reduced
19
Closed
11
Calls
$342K
Puts
$278K
Net Calls
+$64K
Net Calls Change
+$120K

Top Buyers

1
BlackRock
BlackRock
New York
+$11.5M
2
Neuberger Berman Group
Neuberger Berman Group
New York
+$4.48M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.23M
4
HVC
Healthcare Value Capital
New Jersey
+$1.74M
5
PAM
Panagora Asset Management
Massachusetts
+$1.07M

Top Sellers

1
WA
Wasatch Advisors
Utah
-$7.75M
2
Capital World Investors
Capital World Investors
California
-$5.82M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.17M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$317K
5
Morgan Stanley
Morgan Stanley
New York
-$290K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
76
Citigroup
New York
$1K +$1.38K +218 New
GT
77
Glenmede Trust
Pennsylvania
$1K +$1.49K +235 New
BNP Paribas Financial Markets
78
BNP Paribas Financial Markets
France
$592 -$9.36K -1,477 -93%
Walleye Trading
79
Walleye Trading
New York
$51 +$57K +9,000 New
Capital World Investors
80
Capital World Investors
California
– -$5.82M -800,000 Closed
Fidelity Investments
81
Fidelity Investments
Massachusetts
– -$1.17M -160,000 Closed
Susquehanna International Group
82
Susquehanna International Group
Pennsylvania
– -$317K -43,505 Closed
Millennium Management
83
Millennium Management
New York
– -$160K -22,033 Closed
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
– -$151K -20,789 Closed
Squarepoint
85
Squarepoint
New York
– -$138K -18,936 Closed
KeyBank National Association
86
KeyBank National Association
Ohio
– -$123K -16,927 Closed
AQR Capital Management
87
AQR Capital Management
Connecticut
– -$119K -16,367 Closed
CS
88
Credit Suisse
Switzerland
– -$83K -11,365 Closed
PPA
89
Parametric Portfolio Associates
Washington
– -$76K -10,391 Closed
TRCT
90
Tower Research Capital (TRC)
New York
– -$1K -173 Closed
1 2 3
4

LAB Hedge Fund Activity: Q1 2017 in Review

80 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2017, worth a combined $154M — down 21% from $196M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LAB positions and 11 closed out — a net gain of 2 holders — while 29 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock, adding an estimated $11.5M. The largest seller was Wasatch Advisors, cutting an estimated $7.75M.

  • 80 institutional investors held Standard BioTools (LAB) as of Q1 2017, down from 83 in Q4 2016.
  • Funds reported $154M of Standard BioTools stock for Q1 2017, down 21% quarter-over-quarter.
  • 13 funds opened new Standard BioTools positions in Q1 2017 and 11 closed out, a net change of +2 holders.
  • The largest Standard BioTools buyer in Q1 2017 was BlackRock, an estimated $11.5M added.
  • The largest Standard BioTools seller in Q1 2017 was Wasatch Advisors, an estimated $7.75M sold.

Based on aggregated 13F filings for Q1 2017.